Effects of sodium-glucose transporter-2 inhibition on systemic hemodynamics, renal function, and intra-renal oxygenation in sepsis-associated acute kidney injury

Abstract Background People with type 2 diabetes mellitus treated with sodium-glucose transporter-2 inhibitors (SGLT2i) have lower rates of acute kidney injury (AKI). Sepsis is responsible for the majority of AKI in critically ill patients. This study investigated whether SGLT2i is renoprotective in...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Abraham H. Hulst, Connie P. C. Ow, Clive N. May, Sally H. Hood, Mark P. Plummer, Jeroen Hermanides, Daniël H. van Raalte, Adam M. Deane, Rinaldo Bellomo, Yugeesh R. Lankadeva
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	SpringerOpen 2024-07-01
Seri Bilgileri:	Intensive Care Medicine Experimental
Konular:	Sodium-glucose transporter 2 inhibitor Empagliflozin Sepsis Acute kidney injury Medullary oxygenation
Online Erişim:	https://doi.org/10.1186/s40635-024-00647-2
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!